Independent cancer second opinion for patients in Singapore
For patients in Singapore, Malaysia and Southeast Asia. Kim reviews Signatera and genomic profiling reports and searches trials in Singapore, across Asia and in the US.
What Kim reviews
- Pathology and tumor profiling (NGS) reports, including FoundationOne, Caris, Tempus and Guardant360
- Signatera and other ctDNA results
- Clinical trials that fit your molecular profile, locally and internationally
- Written questions and evidence your oncologist can act on
Price and scheduling
Every engagement starts with a free 15-minute call. No records or payment needed, and no obligation. The Clarity Report is USD $2,000 (about S$2,750). Active Case Management: $4,500 / month; Concierge Advisory: $7,500 / month.
Video calls in SGT. Paid receipts are suitable for Integrated Shield Plan riders and private international insurance where policies allow.
All fees are in US dollars and payable online by card. Calls are scheduled to fit your time zone. Records in languages other than English may require translation before review.
Calls are with Kim Lockheimer, PhD, DFM, Chief Scientific Officer. Prices in local currency: /sg/pricing.
Advisory only: diagnosis and treatment stay with your treating oncologist.
Guides for patients
- Signatera test in Singapore
- FoundationOne report explained
- Focused Report Review: one report, one question